Position in GOSS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,278,750
-$1,271,000 QoQ
Shares Held
7,750,000
0.0% QoQ
Ownership
1.59%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#14
of 168 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GOSS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Octagon Capital Advisors LP holds $1,046,707,283 across 25 Biotechnology names. GOSS ranks #25 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
1,841,667 | $179,525,699 | |
| 2 | DFTX |
Definium Therapeutics, Inc.
|
2,950,000 | $138,768,000 | |
| 3 | ABVX |
Abivax S.A.
|
993,000 | $132,327,180 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
2,350,000 | $90,945,000 | |
| 5 | ALMS |
Alumis Inc.
|
2,830,700 | $79,655,898 | |
| 6 | AVBP |
ArriVent BioPharma, Inc.
|
1,971,054 | $68,474,415 | |
| 7 | TSHA |
Taysha Gene Therapies, Inc.
|
9,693,244 | $66,010,991 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
338,900 | $39,675,023 |
All Filings in GOSS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,278,750 | 7,750,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,953,121 | 8,976,054 | Shares | Sole | 2026-05-14 | |
| 2026-03-31 | $2,549,750 | 7,750,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $43,137,650 | 13,915,371 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $44,841,500 | 17,050,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $22,570,500 | 18,350,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $20,185,000 | 18,350,000 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $16,606,750 | 18,350,000 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $17,716,328 | 19,576,054 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $9,059,252 | 9,187,883 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $8,278,282 | 9,187,883 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,841,701 | 9,187,883 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,388,537 | 9,187,883 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,820,506 | 8,187,883 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,749,682 | 3,958,069 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,467,166 | 1,958,069 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,249,009 | 1,958,069 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $24,504,395 | 2,045,442 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $23,085,037 | 2,758,069 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,248,037 | 2,563,138 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $17,113,590 | 1,513,138 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $19,020,144 | 1,513,138 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,474,680 | 1,413,138 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $13,071,526 | 1,413,138 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $15,115,544 | 1,563,138 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||